NCT02766179

Brief Summary

The objectives of this study is to compare short-term outcomes of CPAP and Adjustable thermoplastic oral appliance in the treatment of obstructive sleep apnea. Study design is a randomized cross-over trial during 6-week period of each treatment in 50 patients. Primary outcomes are quality of life, degree of sleepiness, and severity of OSA determined by FOSQ ESS, and AHI or RDI, respectively.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable quality-of-life

Timeline
Completed

Started Oct 2014

Typical duration for not_applicable quality-of-life

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

May 4, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 9, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

May 9, 2016

Status Verified

May 1, 2016

Enrollment Period

2.2 years

First QC Date

May 4, 2016

Last Update Submit

May 6, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quality of life

    FOSQ scores

    6 weeks

Secondary Outcomes (5)

  • side effects

    6 weeks

  • satisfaction

    6 weeks

  • AHI

    6 weeks

  • Degree of sleepiness

    6 weeks

  • lowest oxygen saturation

    6 weeks

Study Arms (2)

CPAP Therapy

ACTIVE COMPARATOR

Continuous Positive Airway Pressure

Device: CPAP

Somnoguard

EXPERIMENTAL

Somnoguard

Device: Somnoguard

Interventions

CPAPDEVICE

CPAP is used for 6 weeks

Also known as: Continuous positive airway pressure therapy
CPAP Therapy

Somnoguard is used for 6 weeks

Somnoguard

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • OSA patients aged over 18 YO at Siriraj hospital
  • AHI 5 - 30 events/ h or AHI \> 30 events/h but lowest O2 saturation \> 70%
  • Positive consented form

You may not qualify if:

  • Patients with severe Temporomandibular joint diseases or limited mandible advancement (\< 5 mm)
  • Patients with severe periodontal diseases or inadequate teeth (\< 3 teeth in each quadrant)
  • Patients with unstable medical problems i.e. poorly controlled cardiovascular diseases, COPD, cancers, cerebrovascular diseases, epilepsy, dementia, etc.
  • Patients who could not tolerate the side effects of CPAP or SMG
  • Patients who could not follow-up until finishing the protocol or withdraw themselves from the study for any reasons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Siriraj Hospital

Bangkok, Bangkok, 10700, Thailand

RECRUITING

Related Publications (1)

  • Banhiran W, Assanasen P, Nopmaneejumrudlers C, Nujchanart N, Srechareon W, Chongkolwatana C, Metheetrairut C. Adjustable thermoplastic oral appliance versus positive airway pressure for obstructive sleep apnea. Laryngoscope. 2018 Feb;128(2):516-522. doi: 10.1002/lary.26753. Epub 2017 Jul 17.

MeSH Terms

Conditions

Sleep Apnea Syndromes

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Wish Banhiran, MD

    Siriraj Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Wish Banhiran, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 4, 2016

First Posted

May 9, 2016

Study Start

October 1, 2014

Primary Completion

December 1, 2016

Study Completion

December 1, 2016

Last Updated

May 9, 2016

Record last verified: 2016-05

Data Sharing

IPD Sharing
Will not share

Locations